Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 731

1.

Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: a Systematic Review and Meta-Analysis.

Roos VH, Mangas-Sanjuan C, Rodriguez-Girondo M, Prado LM, Steyerberg EW, Bossuyt PMM, Dekker E, Jover R, van Leerdam ME.

Clin Gastroenterol Hepatol. 2019 Sep 13. pii: S1542-3565(19)30995-4. doi: 10.1016/j.cgh.2019.09.007. [Epub ahead of print] Review.

PMID:
31525516
2.

Interventions for unexplained infertility: a systematic review and network meta-analysis.

Wang R, Danhof NA, Tjon-Kon-Fat RI, Eijkemans MJ, Bossuyt PM, Mochtar MH, van der Veen F, Bhattacharya S, Mol BWJ, van Wely M.

Cochrane Database Syst Rev. 2019 Sep 5;9:CD012692. doi: 10.1002/14651858.CD012692.pub2. [Epub ahead of print] Review.

PMID:
31486548
3.

Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.

Grobbee EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, Mallant-Hent RC, Lansdorp-Vogelaar I, Bossuyt PMM, Kuipers EJ, Dekker E, Spaander MCW.

Clin Gastroenterol Hepatol. 2019 Aug 13. pii: S1542-3565(19)30890-0. doi: 10.1016/j.cgh.2019.08.015. [Epub ahead of print]

PMID:
31419575
4.

The harms of early cessation of trials on systematic reviews - Authors' reply.

Dijkgraaf MG, van Hilst J, Bossuyt PM, Besselink MG; Dutch Pancreatic Cancer Group.

Lancet Gastroenterol Hepatol. 2019 Sep;4(9):667-668. doi: 10.1016/S2468-1253(19)30228-6. No abstract available.

PMID:
31387729
5.

Publication bias may exist among prognostic accuracy studies of middle cerebral artery Doppler ultrasound.

Vollgraff Heidweiller-Schreurs CA, Korevaar DA, Mol BWJ, Bax CJ, de Groot CJM, de Boer MA, Bossuyt PMM.

J Clin Epidemiol. 2019 Jul 30;116:1-8. doi: 10.1016/j.jclinepi.2019.07.016. [Epub ahead of print] Review.

PMID:
31374330
6.

A systematic review finds that spin or interpretation bias is abundant in evaluations of ovarian cancer biomarkers.

Ghannad M, Olsen M, Boutron I, Bossuyt PM.

J Clin Epidemiol. 2019 Jul 19;116:9-17. doi: 10.1016/j.jclinepi.2019.07.011. [Epub ahead of print] Review.

7.

Challenges of rapid reviews for diagnostic test accuracy questions: a protocol for an international survey and expert consultation.

Arevalo-Rodriguez I, Tricco AC, Steingart KR, Nussbaumer-Streit B, Kaunelis D, Alonso-Coello P, Baxter S, Bossuyt PM, Zamora J.

Diagn Progn Res. 2019 Apr 4;3:7. doi: 10.1186/s41512-019-0052-y. eCollection 2019.

8.

OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose CT (OPTIMACT)-a randomised controlled trial chest X-ray or ultra-low-dose CT at the ED: design and rationale.

van den Berk IAH, Kanglie MMNP, van Engelen TSR, Bipat S, Dijkgraaf MGW, Bossuyt PMM, de Monyé W, Prins JM, Stoker J.

Diagn Progn Res. 2018 Aug 8;2:20. doi: 10.1186/s41512-018-0038-1. eCollection 2018.

9.

Diagnostic accuracy studies need more informative abstracts.

Cohen JF, Korevaar DA, Bossuyt PM.

Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1383-1385. doi: 10.1007/s10096-019-03570-7. No abstract available.

PMID:
31049744
10.

Setting clinical performance specifications to develop and evaluate biomarkers for clinical use.

Lord SJ, St John A, Bossuyt PM, Sandberg S, Monaghan PJ, O'Kane M, Cobbaert CM, Röddiger R, Lennartz L, Gelfi C, Horvath AR; Test Evaluation Working Group of the European Federation of Clinical Chemistry and Laboratory Medicine.

Ann Clin Biochem. 2019 Sep;56(5):527-535. doi: 10.1177/0004563219842265. Epub 2019 Apr 16. No abstract available.

PMID:
30987429
11.

Test evaluation: major challengesahead - Opportunities abound.

Monaghan PJ, Bossuyt PM.

Ann Clin Biochem. 2019 Sep;56(5):524-526. doi: 10.1177/0004563219837301. Epub 2019 Apr 11. No abstract available.

PMID:
30971105
12.

Always randomize as late as possible.

van Werkhoven E, Tajik P, Bossuyt PM.

Gastric Cancer. 2019 Apr 8. doi: 10.1007/s10120-019-00959-3. [Epub ahead of print] No abstract available.

PMID:
30963320
13.

Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review.

Olsen M, Ghannad M, Lok C, Bossuyt PM.

Clin Chem Lab Med. 2019 Apr 8. pii: /j/cclm.ahead-of-print/cclm-2019-0038/cclm-2019-0038.xml. doi: 10.1515/cclm-2019-0038. [Epub ahead of print] Review.

PMID:
30956227
14.

Participation and Ease of Use in Colorectal Cancer Screening: A Comparison of 2 Fecal Immunochemical Tests.

de Klerk CM, Wieten E, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MCW, Dekker E.

Am J Gastroenterol. 2019 Mar;114(3):511-518. doi: 10.14309/ajg.0000000000000148.

PMID:
30789417
15.

Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.

Keulen JK, Bruinsma A, Kortekaas JC, van Dillen J, Bossuyt PM, Oudijk MA, Duijnhoven RG, van Kaam AH, Vandenbussche FP, van der Post JA, Mol BW, de Miranda E.

BMJ. 2019 Feb 20;364:l344. doi: 10.1136/bmj.l344.

16.

Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.

Jara-Palomares L, van Es N, Praena-Fernandez JM, Le Gal G, Otten HM, Robin P, Piccioli A, Lecumberri R, Religa P, Rieu V, Rondina M, Beckers M, Prandoni P, Salaun PY, Di Nisio M, Bossuyt PM, Kraaijpoel N, Büller HR, Carrier M.

Thromb Res. 2019 Apr;176:79-84. doi: 10.1016/j.thromres.2019.02.011. Epub 2019 Feb 13.

PMID:
30780008
17.

GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations.

Schünemann HJ, Mustafa RA, Brozek J, Santesso N, Bossuyt PM, Steingart KR, Leeflang M, Lange S, Trenti T, Langendam M, Scholten R, Hooft L, Murad MH, Jaeschke R, Rutjes A, Singh J, Helfand M, Glasziou P, Arevalo-Rodriguez I, Akl EA, Deeks JJ, Guyatt GH; GRADE Working Group.

J Clin Epidemiol. 2019 Jul;111:69-82. doi: 10.1016/j.jclinepi.2019.02.003. Epub 2019 Feb 7.

PMID:
30738926
18.

Impact and perceived value of journal reporting guidelines among Radiology authors and reviewers.

Dewey M, Levine D, Bossuyt PM, Kressel HY.

Eur Radiol. 2019 Aug;29(8):3986-3995. doi: 10.1007/s00330-018-5980-3. Epub 2019 Jan 29.

PMID:
30694365
19.

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.

Mulder FI, Candeloro M, Kamphuisen PW, Di Nisio M, Bossuyt PM, Guman N, Smit K, Büller HR, van Es N; CAT-prediction collaborators.

Haematologica. 2019 Jun;104(6):1277-1287. doi: 10.3324/haematol.2018.209114. Epub 2019 Jan 3.

20.

Frequent premature atrial contractions are associated with atrial fibrillation, brain ischaemia, and mortality: a systematic review and meta-analysis.

Himmelreich JCL, Lucassen WAM, Heugen M, Bossuyt PMM, Tan HL, Harskamp RE, van Etten-Jamaludin FS, van Weert HCPM.

Europace. 2019 May 1;21(5):698-707. doi: 10.1093/europace/euy276.

PMID:
30508087
21.

Invitees do not adequately act on alarm symptoms in colorectal cancer screening with fecal immunochemical tests.

de Klerk CM, Woudstra AJ, Fransen MP, Bossuyt PM, Dekker E.

Eur J Gastroenterol Hepatol. 2019 Jan;31(1):141-142. doi: 10.1097/MEG.0000000000001275. No abstract available.

PMID:
30507642
22.

Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.

de Klerk CM, Wieten E, Lansdorp-Vogelaar I, Bossuyt PM, Spaander MC, Dekker E.

Lancet Gastroenterol Hepatol. 2019 Feb;4(2):111-118. doi: 10.1016/S2468-1253(18)30319-4. Epub 2018 Nov 27.

PMID:
30497962
23.

Patient-Centered Outcomes Related to Imaging Testing in US Primary Care.

Zigman Suchsland ML, Witwer E, Truitt AR, Lavallee DC, Zhang Y, Posner P, Do B, Bossuyt PM, Hardy V, Thompson MJ.

J Am Coll Radiol. 2019 Feb;16(2):156-163. doi: 10.1016/j.jacr.2018.08.021. Epub 2018 Oct 25.

PMID:
30482736
24.

Citation bias in imaging research: are studies with higher diagnostic accuracy estimates cited more often?

Frank RA, Sharifabadi AD, Salameh JP, McGrath TA, Kraaijpoel N, Dang W, Li N, Gauthier ID, Wu MZ, Bossuyt PM, Levine D, McInnes MDF.

Eur Radiol. 2019 Apr;29(4):1657-1664. doi: 10.1007/s00330-018-5801-8. Epub 2018 Nov 15.

PMID:
30443756
25.

Completeness of Reporting of Systematic Reviews of Diagnostic Test Accuracy Based on the PRISMA-DTA Reporting Guideline.

Salameh JP, McInnes MDF, Moher D, Thombs BD, McGrath TA, Frank R, Dehmoobad Sharifabadi A, Kraaijpoel N, Levis B, Bossuyt PM.

Clin Chem. 2019 Feb;65(2):291-301. doi: 10.1373/clinchem.2018.292987. Epub 2018 Sep 20.

PMID:
30237150
26.

Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.

de Klerk CM, Vendrig LM, Bossuyt PM, Dekker E.

Am J Gastroenterol. 2018 Dec;113(12):1778-1787. doi: 10.1038/s41395-018-0212-7. Epub 2018 Aug 29.

PMID:
30158713
27.

Best practices for MRI systematic reviews and meta-analyses.

McGrath TA, Bossuyt PM, Cronin P, Salameh JP, Kraaijpoel N, Schieda N, McInnes MDF.

J Magn Reson Imaging. 2019 Jun;49(7):e51-e64. doi: 10.1002/jmri.26198. Epub 2018 Aug 13. Review.

PMID:
30102435
28.

Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial.

Verpoest W, Staessen C, Bossuyt PM, Goossens V, Altarescu G, Bonduelle M, Devesa M, Eldar-Geva T, Gianaroli L, Griesinger G, Kakourou G, Kokkali G, Liebenthron J, Magli MC, Parriego M, Schmutzler AG, Tobler M, van der Ven K, Geraedts J, Sermon K.

Hum Reprod. 2018 Sep 1;33(9):1767-1776. doi: 10.1093/humrep/dey262.

PMID:
30085138
29.

Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.

Wieten E, de Klerk CM, van der Steen A, Ramakers CR, Kuipers EJ, Hansen BE, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.

Gastroenterology. 2018 Nov;155(5):1392-1399.e5. doi: 10.1053/j.gastro.2018.07.021. Epub 2018 Jul 25.

PMID:
30055170
30.

Practical guide for identifying unmet clinical needs for biomarkers.

Monaghan PJ, Robinson S, Rajdl D, Bossuyt PMM, Sandberg S, St John A, O'Kane M, Lennartz L, Röddiger R, Lord SJ, Cobbaert CM, Horvath AR.

EJIFCC. 2018 Jul 11;29(2):129-137. eCollection 2018 Jul.

31.

[Real-world data are an addition to randomised research].

Bossuyt PMM.

Ned Tijdschr Geneeskd. 2018 Jun 15;162. pii: D3040. Dutch.

PMID:
30040335
32.

Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy: The PRISMA-DTA Statement.

Frank RA, Bossuyt PM, McInnes MDF.

Radiology. 2018 Nov;289(2):313-314. doi: 10.1148/radiol.2018180850. Epub 2018 Jul 17. No abstract available.

PMID:
30015590
33.

Screening for child abuse using a checklist and physical examinations in the emergency department led to the detection of more cases.

Teeuw AH, Kraan RBJ, van Rijn RR, Bossuyt PMM, Heymans HSA.

Acta Paediatr. 2019 Feb;108(2):300-313. doi: 10.1111/apa.14495. Epub 2018 Aug 14.

PMID:
29992712
34.

Development and evaluating multimarker models for guiding treatment decisions.

Tajik P, Zafarmand MH, Zwinderman AH, Mol BW, Bossuyt PM.

BMC Med Inform Decis Mak. 2018 Jun 28;18(1):52. doi: 10.1186/s12911-018-0619-5.

35.

Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients.

Mol BW, Bossuyt PM, Sunkara SK, Garcia Velasco JA, Venetis C, Sakkas D, Lundin K, Simón C, Taylor HS, Wan R, Longobardi S, Cottell E, D'Hooghe T.

Fertil Steril. 2018 Jun;109(6):968-979. doi: 10.1016/j.fertnstert.2018.04.037. Review.

36.

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic.

de Klerk CM, van der Vlugt M, Bossuyt PM, Dekker E.

United European Gastroenterol J. 2018 Apr;6(3):471-479. doi: 10.1177/2050640617733922. Epub 2017 Sep 24.

37.

Prognostic value of cardiovascular parameters in computed tomography pulmonary angiography in patients with acute pulmonary embolism.

Beenen LFM, Bossuyt PMM, Stoker J, Middeldorp S.

Eur Respir J. 2018 Jul 4;52(1). pii: 1702611. doi: 10.1183/13993003.02611-2017. Print 2018 Jul.

PMID:
29773691
38.

The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial.

van Rijswijk J, van Welie N, Dreyer K, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, Kleiman-Broeze KA, Traas MAF, Muijsers GJJM, Manger AP, Gianotten J, de Koning CH, Koning AMH, Bayram N, van der Ham DP, Vrouenraets FPJM, Kalafusova M, van de Laar BIG, Kaijser J, van Oostwaard MF, Meijer WJ, Broekmans FJM, Valkenburg O, van der Voet LF, van Disseldorp J, Lambers MJ, Peters HE, Lier MCI, Lambalk CB, van Wely M, Bossuyt PMM, Stoker J, van der Veen F, Mol BWJ, Mijatovic V.

BMC Womens Health. 2018 May 9;18(1):64. doi: 10.1186/s12905-018-0556-6.

39.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment.

Kraaijpoel N, Toorop MMA, Bossuyt PM, Klok FA, Büller HR, van Es N.

J Thromb Haemost. 2018 Jul;16(7):1445-1448. doi: 10.1111/jth.14133. Epub 2018 Jun 12. No abstract available.

PMID:
29733495
40.

From the theoretical to the practical: how to evaluate the ethical and scientific justifications of randomized clinical trials.

Olsen M, Sharp MK, Bossuyt PM.

J Clin Epidemiol. 2018 Jul;99:170-171. doi: 10.1016/j.jclinepi.2018.03.008. Epub 2018 Mar 26. No abstract available.

41.

Natural conception rates in couples with unexplained or mild male subfertility scheduled for fertility treatment: a secondary analysis of a randomized controlled trial.

van Eekelen R, Tjon-Kon-Fat RI, Bossuyt PMM, van Geloven N, Eijkemans MJC, Bensdorp AJ, van der Veen F, Mol BW, van Wely M.

Hum Reprod. 2018 May 1;33(5):919-923. doi: 10.1093/humrep/dey051.

PMID:
29538638
42.

Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.

van der Vlugt M, Grobbee EJ, Bossuyt PM, Bos ACRK, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1237-1243.e2. doi: 10.1016/j.cgh.2018.01.037. Epub 2018 Feb 7.

PMID:
29427732
43.

Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.

McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; the PRISMA-DTA Group, Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA, Hyde CJ, Korevaar DA, Leeflang MMG, Macaskill P, Reitsma JB, Rodin R, Rutjes AWS, Salameh JP, Stevens A, Takwoingi Y, Tonelli M, Weeks L, Whiting P, Willis BH.

JAMA. 2018 Jan 23;319(4):388-396. doi: 10.1001/jama.2017.19163.

PMID:
29362800
44.

Reply.

van der Vlugt M, Dekker E, Bossuyt PM.

Gastroenterology. 2018 Feb;154(3):763-764. doi: 10.1053/j.gastro.2018.01.020. Epub 2018 Jan 17. No abstract available.

PMID:
29352953
45.

Current and Emerging Multianalyte Assays with Algorithmic Analyses-Are Laboratories Ready for Clinical Adoption?

Colón-Franco JM, Bossuyt PMM, Algeciras-Schimnich A, Bird C, Engstrom-Melnyk J, Fleisher M, Kattan M, Lambert-Messerlian G.

Clin Chem. 2018 Jun;64(6):885-891. doi: 10.1373/clinchem.2017.275677. Epub 2018 Jan 17. No abstract available.

46.

The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy.

Tajik P, van de Vrie R, Zafarmand MH, Coens C, Buist MR, Vergote I, Bossuyt PMM, Kenter GG.

Int J Gynecol Cancer. 2018 Mar;28(3):453-458. doi: 10.1097/IGC.0000000000001186.

PMID:
29324537
47.

The development of CHAMP: a checklist for the appraisal of moderators and predictors.

van Hoorn R, Tummers M, Booth A, Gerhardus A, Rehfuess E, Hind D, Bossuyt PM, Welch V, Debray TPA, Underwood M, Cuijpers P, Kraemer H, van der Wilt GJ, Kievit W.

BMC Med Res Methodol. 2017 Dec 21;17(1):173. doi: 10.1186/s12874-017-0451-0.

48.

Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.

Lemmers M, Verschoor MAC, Bossuyt PM, Huirne JAF, Spinder T, Nieboer TE, Bongers MY, Janssen IAH, Van Hooff MHA, Mol BWJ, Ankum WM, Bosmans JE; MisoREST study group.

Acta Obstet Gynecol Scand. 2018 Mar;97(3):294-300. doi: 10.1111/aogs.13283. Epub 2018 Jan 19.

PMID:
29266169
49.

Are Study and Journal Characteristics Reliable Indicators of "Truth" in Imaging Research?

Frank RA, McInnes MDF, Levine D, Kressel HY, Jesurum JS, Petrcich W, McGrath TA, Bossuyt PM.

Radiology. 2018 Apr;287(1):215-223. doi: 10.1148/radiol.2017170586. Epub 2017 Nov 27. Review.

PMID:
29173122
50.

Selecting pH cut-offs for the safe verification of nasogastric feeding tube placement: a decision analytical modelling approach.

Ni MZ, Huddy JR, Priest OH, Olsen S, Phillips LD, Bossuyt PMM, Hanna GB.

BMJ Open. 2017 Nov 4;7(11):e018128. doi: 10.1136/bmjopen-2017-018128. Erratum in: BMJ Open. 2018 Jan 21;8(1):e018128corr1.

Supplemental Content

Loading ...
Support Center